The eXpeRience registry: The 'real-world' effectiveness of omalizumab in allergic asthma

Respiratory Medicine

Volumn 107, Issue 8, 2013, Pages 1141-1151

  Braunstahl, G J ^a   Chen, C W ^b   Maykut, R ^b   Georgiou, P ^c   Peachey, G ^c   Bruce, J ^b  

^a SINT FRANCISCUS GASTHUIS   (Netherlands)

^b NOVARTIS PHARMA AG   (Switzerland)

^c NOVARTIS HORSHAM RESEARCH CENTRE   (United Kingdom)

Author keywords

Allergic asthma; Anti immunoglobulin E; Asthma control; Exacerbations; Symptoms

Indexed keywords

OMALIZUMAB;

ADOLESCENT; ADULT; AGED; ALLERGIC ASTHMA; ANAPHYLAXIS; ARTICLE; ASTHMA; CHILD; DISEASE EXACERBATION; DIZZINESS; DRUG EFFICACY; DRUG INDUCED HEADACHE; DRUG SAFETY; DYSPNEA; EDEMA; FEMALE; FLUSHING; GASTROINTESTINAL DISEASE; HUMAN; HYPERHIDROSIS; HYPOTENSION; INFECTION; INFESTATION; INTOXICATION; LUNG FUNCTION; MAJOR CLINICAL STUDY; MALE; MISSED ABORTION; OBSERVATIONAL STUDY; OPEN STUDY; OUTCOME ASSESSMENT; OXYGEN SATURATION; PRIORITY JOURNAL; SCHOOL CHILD; SEPSIS; SIDE EFFECT; SKIN DISEASE; SPONTANEOUS ABORTION; THORAX PAIN; TREMOR; XEROSTOMIA;

EID: 84880826189     PISSN: 09546111     EISSN: 15323064     Source Type: Journal    
DOI: 10.1016/j.rmed.2013.04.017     Document Type: Article

References (36)

1. S.P. Peters, G. Ferguson, Y. Deniz, and C. Reisner Uncontrolled asthma: a review of the prevalence, disease burden and options for treatment Respir Med 100 2006 1139 1151 (Pubitemid 43793051)
2. J. Rees Asthma control in adults BMJ 332 2006 767 771 (Pubitemid 44365654)
3. B. Bender, H. Milgrom, and C. Rand Nonadherence in asthmatic patients: is there a solution to the problem? Ann Allergy Asthma Immunol 79 1997 177 186 (Pubitemid 27499970)
4. V. Giraud, and N. Roche Misuse of corticosteroid metered-dose inhaler is associated with decreased asthma stability Eur Respir J 19 2002 246 251 (Pubitemid 34162824)
5. J. Bousquet, P. Cabrera, N. Berkman, R. Buhl, S. Holgate, and S. Wenzel The effect of treatment with omalizumab, an anti-IgE antibody, on asthma exacerbations and emergency medical visits in patients with severe persistent asthma Allergy 60 2005 302 308 (Pubitemid 40293345)
6. J. Bousquet, Z. Siergiejko, E. Swiebocka, M. Humbert, K.F. Rabe, and N. Smith Persistency of response to omalizumab therapy in severe allergic (IgE-mediated) asthma Allergy 66 2011 671 678
7. W. Busse, J. Corren, B.Q. Lanier, M. McAlary, A. Fowler-Taylor, and G.D. Cioppa Omalizumab, anti-IgE recombinant humanized monoclonal antibody, for the treatment of severe allergic asthma J Allergy Clin Immunol 108 2001 184 190 (Pubitemid 32735398)
8. W.W. Busse, W.J. Morgan, P.J. Gergen, H.E. Mitchell, J.E. Gern, and A.H. Liu Randomized trial of omalizumab (anti-IgE) for asthma in inner-city children N Engl J Med 364 2011 1005 1015
9. N.A. Hanania, O. Alpan, D.L. Hamilos, J.J. Condemi, I. Reyes-Rivera, and J. Zhu Omalizumab in severe allergic asthma inadequately controlled with standard therapy: a randomized trial Ann Intern Med 154 2011 573 582
10. S.T. Holgate, A.G. Chuchalin, J. Hebert, J. Lötvall, G.B. Persson, K.F. Chung Omalizumab 011 International Study Group Efficacy and safety of a recombinant anti-immunoglobulin E antibody (omalizumab) in severe allergic asthma Clin Exp Allergy 34 2004 632 638 (Pubitemid 38534897)
11. M. Humbert, R. Beasley, J. Ayres, R. Slavin, J. Hébert, and J. Bousquet Benefits of omalizumab as add-on therapy in patients with severe persistent asthma who are inadequately controlled despite best available therapy (GINA 2002 step 4 treatment): INNOVATE Allergy 60 2005 309 316 (Pubitemid 40293346)
12. M. Kulus, J. Hebert, E. Garcia, A. Fowler Taylor, C. Fernandez Vidaurre, and M. Blogg Omalizumab in children with inadequately controlled severe allergic (IgE-mediated) asthma Curr Med Res Opin 26 2010 1285 1293
13. B. Lanier, T. Bridges, M. Kulus, A.F. Taylor, I. Berhane, and C.F. Vidaurre Omalizumab for the treatment of exacerbations in children with inadequately controlled allergic (IgE-mediated) asthma J Allergy Clin Immunol 124 2009 1210 1216
14. M. Soler, J. Matz, R. Townley, R. Buhl, J. O'Brien, and H. Fox The anti-IgE antibody omalizumab reduces exacerbations and steroid requirement in allergic asthmatics Eur Respir J 18 2001 254 261 (Pubitemid 32776398)
15. J.M. Fitzgerald, P.P. Ernst, and S. Field XCEED: Xolair Canadian Evaluation of Effectiveness in Asthmatic Disease Allergy Asthma Clin Immunol 4 Suppl. 2008 [abstract]
16. N. Thomson, R. Niven, L. Heaney, and A. Greening Development of an algorithm for the assessment of response to treatment with omalizumab Thorax 62 Suppl. 3 2007 [abstract]
17. Global Initiative for Asthma. Global strategy for asthma management and prevention. Issued January 1995 (NIH Publication No. 02-3659); revised 2006. Available at: http://www.ginasthma.org [accessed 18.11.11].
18. R.A. Nathan, C.A. Sorkness, M. Kosinski, M. Schatz, J.T. Li, and P. Marcus Development of the asthma control test: a survey for assessing asthma control J Allergy Clin Immunol 113 2004 59 65 (Pubitemid 38096162)
19. M. Schatz, M. Kosinski, A.S. Yarlas, J. Hanlon, M.E. Watson, and P. Jhingran The minimally important difference of the Asthma Control Test J Allergy Clin Immunol 124 2009 719 723
20. E.F. Juniper, P.M. O'Byrne, G.H. Guyatt, P.J. Ferrie, and D.R. King Development and validation of a questionnaire to measure asthma control Eur Respir J 14 1999 902 907 (Pubitemid 29519356)
21. E.F. Juniper, K. Svensson, A.C. Mork, and E. Ståhl Measurement properties and interpretation of three shortened versions of the asthma control questionnaire Respir Med 99 2005 553 558 (Pubitemid 40468501)
22. E.F. Juniper, G.H. Guyatt, A. Willan, and L.E. Griffith Determining a minimal important change in a disease-specific quality of life questionnaire J Clin Epidemiol 47 1994 81 87 (Pubitemid 24034293)
23. E.F. Juniper, G.H. Guyatt, F.M. Cox, P.J. Ferrie, and D.R. King Development and validation of the mini asthma quality of life questionnaire Eur Respir J 14 1999 32 38 (Pubitemid 29411232)
24. P.O. Ehrs, M. Nokela, B. Stallberg, P. Hjemdahl, and E. Wikström Jonsson Brief questionnaires for patient-reported outcomes in asthma: validation and usefulness in a primary care setting Chest 129 2006 925 932
25. G.J. Braunstahl, J. Leo, J. Thirlwell, G. Peachey, and R. Maykut Uncontrolled persistent allergic asthma in practice: eXpeRience registry baseline characteristics Curr Med Res Opin 27 2011 761 767
26. R. Niven, A. Radwan APEX Study Investigators The APEX study: a retrospective review of responses of severe allergic asthma patients to omalizumab on continuous or non-continuous oral corticosteroids in UK clinical practice Eur Respir J 38 Suppl. 55 2011 24s [abstract]
27. G. Brusselle, A. Michils, R. Louis, L. Dupont, B. Van de Maele, and A. Delobbe "Real-life" effectiveness of omalizumab in patients with severe persistent allergic asthma: the PERSIST study Respir Med 103 2009 1633 1642
28. M. Cazzola, G. Camiciottoli, M. Bonavia, C. Gulotta, A. Ravazzi, and A. Alessandrini Italian real-life experience of omalizumab Respir Med 104 2010 1410 1416
29. S. Korn, C. Schumann, C. Kropf, K. Stoiber, A. Thielen, and C. Taube Effectiveness of omalizumab in patients 50 years and older with severe persistent allergic asthma Ann Allergy Asthma Immunol 105 2010 313 319
30. C. Schumann, C. Kropf, T. Wibmer, S. Rüdiger, K.M. Stoiber, and A. Thielen Omalizumab in patients with severe asthma: the XCLUSIVE study Clin Respir J 6 2012 215 227
31. M.D.C. Vennera, L. Pérez de Llano, S. Bardagí, P. Ausin, C. Sanjuas, and H. González Omalizumab therapy in severe asthma: experience from the Spanish registry - some new approaches J Asthma 49 2012 416 422
32. A.S. Rubin, A. Souza-Machado, M. Andradre-Lima, F. Ferreira, A. Honda, T.M. Matozo QUALITX Study Investigators Effect of omalizumab as add-on therapy on asthma-related quality of life in severe allergic asthma: a Brazilian study (QUALITX) J Asthma 49 2012 288 293
33. E.G. Tzortzaki, A. Georgiou, D. Kampas, M. Lemessios, M. Markatos, and T. Adamidi Long-term omalizumab treatment in severe allergic asthma: The South-Eastern Mediterranean "real-life" experience Pulm Pharmacol Ther 25 2012 77 82
34. S. Korn, A. Thielen, S. Seyfried, C. Taube, O. Kornmann, and R. Buhl Omalizumab in patients with severe persistent allergic asthma in a real-life setting in Germany Respir Med 103 2009 1725 1731
35. E.D. Bateman, H.A. Boushey, J. Bousquet, W.W. Busse, T.J. Clark, and R.A. Pauwels Can guideline-defined asthma control be achieved? The Gaining Optimal Asthma ControL Study Am J Respir Crit Care Med 170 2004 836 844 (Pubitemid 39346477)
36. J. Corren, T.B. Casale, B. Lanier, R. Buhl, S. Holgate, and P. Jimenez Safety and tolerability of omalizumab Clin Exp Allergy 39 2009 788 797